3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Neuroendocrine Tumors
5
Carcinoma, Renal Cell
4
Neoplasm Metastasis
3
Tuberous Sclerosis
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Glioma
2
Endometrial Neoplasms
2
Adenoma, Islet Cell
2
von Hippel-Lindau Disease
1
Vascular Malformations
1
Unilateral Breast Neoplasms
1
Thymus Neoplasms
1
Seizures
1
Sarcoma, Kaposi
1
Sarcoma
1
Nevus
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Lymphangioma
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Hemangioma
1
Hemangioendothelioma
1
Hamartoma Syndrome, Multiple
1
Interventions
Specimen Handling
4
Cyclophosphamide
4
Biopsy
4
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
sodium-iodide symporter
2
pembrolizumab
2
mogamulizumab
2
fludarabine phosphate
2
fludarabine
2
cemiplimab
2
X-Rays
2
Whole-Body Irradiation
2
Tacrolimus
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Immunoglobulin G
2
Disulfides
2
Busulfan
2
Brentuximab Vedotin
2
talimogene laherparepvec
1
ruxolitinib
1
hypericin
1
duvelisib
1
Vorinostat
1
Transplantation
1
Sirolimus
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
Everolimus
×
90 days
×
Clear all
No trials found.